These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16005519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV, Buccafusco JJ, Wilson C.
    Behav Brain Res; 2008 Dec 16; 195(1):30-8. PubMed ID: 18241938
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B, Gil-Bea FJ, Hirst WD, García-Alloza M, Ramírez MJ.
    Eur J Neurosci; 2006 Sep 16; 24(5):1299-306. PubMed ID: 16987217
    [Abstract] [Full Text] [Related]

  • 7. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
    Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.
    Neuropharmacology; 2020 Oct 15; 177():108099. PubMed ID: 32525060
    [Abstract] [Full Text] [Related]

  • 8. 5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes.
    Meneses A, Pérez-García G, Ponce-Lopez T, Castillo C.
    Int Rev Neurobiol; 2011 Oct 15; 96():27-47. PubMed ID: 21329783
    [Abstract] [Full Text] [Related]

  • 9. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ, Smith SL, Fisas A, Codony X, Buschmann H.
    Pharmacol Ther; 2008 Feb 15; 117(2):207-31. PubMed ID: 18068807
    [Abstract] [Full Text] [Related]

  • 10. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN, Ahmed M, Miller ND.
    Curr Opin Drug Discov Devel; 2008 Sep 15; 11(5):642-54. PubMed ID: 18729016
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T, Bubenikova-Valesova V, Horacek J, Bert B.
    Adv Ther; 2008 Oct 15; 25(10):1037-56. PubMed ID: 18839076
    [Abstract] [Full Text] [Related]

  • 13. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.
    Meneses A.
    Rev Neurosci; 2014 Oct 15; 25(3):325-56. PubMed ID: 24698823
    [Abstract] [Full Text] [Related]

  • 14. Antagonism of the 5-HT6 receptor - Preclinical rationale for the treatment of Alzheimer's disease.
    de Jong IEM, Mørk A.
    Neuropharmacology; 2017 Oct 15; 125():50-63. PubMed ID: 28711518
    [Abstract] [Full Text] [Related]

  • 15. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
    Dupuis DS, Mannoury la Cour C, Chaput C, Verrièle L, Lavielle G, Millan MJ.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):170-7. PubMed ID: 18511034
    [Abstract] [Full Text] [Related]

  • 16. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ.
    Bioorg Med Chem Lett; 2009 Jun 15; 19(12):3214-6. PubMed ID: 19433358
    [Abstract] [Full Text] [Related]

  • 17. Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors.
    Marsden CA, King MV, Fone KC.
    Neuropharmacology; 2011 Sep 15; 61(3):400-7. PubMed ID: 21414329
    [Abstract] [Full Text] [Related]

  • 18. Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics.
    Tyson PJ, Laws KR, Flowers KA, Tyson A, Mortimer AM.
    Psychiatry Clin Neurosci; 2006 Aug 15; 60(4):473-9. PubMed ID: 16884450
    [Abstract] [Full Text] [Related]

  • 19. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B, Martín-Fontecha M, Vázquez-Villa H, Pardo L, López-Rodríguez ML.
    J Med Chem; 2014 Sep 11; 57(17):7160-81. PubMed ID: 24850589
    [Abstract] [Full Text] [Related]

  • 20. Serotonin/dopamine interaction in learning.
    Olvera-Cortés ME, Anguiano-Rodríguez P, López-Vázquez MA, Alfaro JM.
    Prog Brain Res; 2008 Sep 11; 172():567-602. PubMed ID: 18772051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.